Michael S Perry, Director, on August 18, 2026, sold 11,600 shares in Arrowhead Pharmaceuticals (ARWR) for $1,012,680. Following the Form 4 filing with the SEC, Perry has control over a total of 111,459 common shares of the company, with 111,459 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/879407/000125037926000002/xslF345X05/wk-form4_1787260939.xml